Freeman Spogli investment in EverVet
We advised Tailwind Capital and EverVet on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
TPG Capital $1.1 billion take-private acquisition of Convey Health Solutions
We are advising TPG Capital on the transaction
Astorg acquisition of OPEN Health
We are advising Astorg on the transaction
GSK $3.3 billion acquisition of Affinivax
We are advising GSK on the acquisition
Bausch + Lomb $630 million IPO
We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market
Acutus Medical sale of its left-heart access portfolio products
We are advising Acutus Medical on the transaction
Ingenovis Health acquisition of VISTA Staffing Solutions
We are advising Ingenovis Health, Cornell Capital and Trilantic on the transaction
Natus Medical $1.2 billion acquisition by ArchiMed
We are advising Natus Medical on the transaction